|
"yeh hong zen"的相關文件
顯示項目 11-18 / 18 (共1頁)
1
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2017-05-15 |
Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus
|
Lee, Shou-Wu;Lien, Han-Chung;Lee, Teng-Yu;Tung, Chun-Fang;Yeh, Hong-Zen;Chang, Chi-Sen |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 國立臺灣大學 |
2009 |
Heparanase Inhibitor Pi-88 as Adjuvant Therapy for Hepatocellular Carcinoma after Curative Resection: A Randomized Phase Ii Trial for Safety and Optimal Dosage
|
劉俊人; 李伯皇; 胡瑞恆; 吳誠中; 鄭隆賓; 林炳文; 莫景棠; 葉宏仁; 何明志; 楊勝舜; 陳培哲; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 國立臺灣大學 |
2009 |
Il-10 Promoter Gene Polymorphisms and Sustained Response to Combination Therapy in Taiwanese Chronic Hepatitis C Patients
|
莊淨媛; 楊勝舜; 張繼森; 葉宏仁; 高嘉宏; CHUANG, JING-YUAN; YANG, SHENG-SHUN; CHANG, CHI-SEN; YEH, HONG-ZEN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2006 |
Changes of Soluble Cd26 and Cd30 Levels Correlate with Response to Interferon Plus Ribavirin Therapy in Patients with Chronic Hepatitis C
|
楊勝舜; 傅令嫻; 張繼森; 葉宏仁; 陳儉鏗; 高嘉宏; YANG, SHENG-SHUN; FU, LIN-SHIEN; CHANG, CHI-SEN; YEH, HONG-ZEN; CHEN, GRAN-HUM; KAO, JIA-HORNG |
| 國立成功大學 |
2005-09-21 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen, Li-Tzong; Lin, Jaw-Town; Tai, John-Jen; Chen, Gran-Hum; Yeh, Hong-Zen; Yang, Sheng-Shun; Wang, Hsiu-Po; Kuo, Sung-Hsin; Sheu, Bor-Shyang; Jan, Chang-Ming; Wang, Wen-Ming; Wang, Tsang-En; Wu, Chew-Wun; Chen, Chi-Long; Su, Ih-Jen; Jacqueline Whang-Peng; Cheng, Ann-Lii |
顯示項目 11-18 / 18 (共1頁)
1
每頁顯示[10|25|50]項目
|
